A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus Macaques

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a worldwide pandemic. Here, we present non-human primate immunogenicity and protective efficacy data generated with the capsid virus-like particle (cVLP)-based vaccine ABNCoV2 that has previously demonstrated immunogenicity in m...

Descripción completa

Detalles Bibliográficos
Autores principales: Volkmann, Ariane, Koopman, Gerrit, Mooij, Petra, Verschoor, Ernst J., Verstrepen, Babs E., Bogers, Willy M. J. M., Idorn, Manja, Paludan, Søren R., Vang, Søren, Nielsen, Morten A., Sander, Adam F., Schmittwolf, Carolin, Hochrein, Hubertus, Chaplin, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037084/
https://www.ncbi.nlm.nih.gov/pubmed/35479095
http://dx.doi.org/10.3389/fimmu.2022.857440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037084/
https://www.ncbi.nlm.nih.gov/pubmed/35479095
http://dx.doi.org/10.3389/fimmu.2022.857440

Ejemplares similares